🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.2253
+0.0115 (5.38%)
At close: Nov 20, 2026, 4:00 PM EST
0.2004
-0.0249 (-11.05%)
After-hours: Nov 20, 2026, 7:56 PM EST

Actuate Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
10.1712.26.483.273.82
Research & Development
8.5710.2918.6821.7116.39
Operating Expenses
18.7422.525.1624.9720.21
Operating Income
-18.74-22.5-25.16-24.97-20.21
Interest Expense
-0.02-0.02-0.02-0.04-0.02
Interest & Investment Income
0.290.290.220.350.03
Other Non Operating Income (Expenses)
--0.26-0.080.04
EBT Excluding Unusual Items
-18.47-22.23-24.69-24.74-20.16
Other Unusual Items
---2.59--
Pretax Income
-18.47-22.23-27.29-24.74-20.16
Net Income
-18.47-22.23-27.29-24.74-20.16
Net Income to Common
-18.47-22.23-27.29-24.74-20.16
Net Income Growth
-----
Shares Outstanding (Basic)
2421811
Shares Outstanding (Diluted)
2421811
Shares Change
18.80%151.07%483.48%18.54%-
EPS (Basic)
-0.78-1.06-3.26-17.24-16.65
EPS (Diluted)
-0.78-1.06-3.26-17.24-16.65
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EBIT
-18.74-22.5-25.16-24.97-20.21
SEC Filings: 10-K · 10-Q